Inhaled glucocorticoids and COPD exacerbations.

Inhaled glucocorticoids and COPD exacerbations.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Brightling, C, Pavord, I, Bafadhel, M
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2015

Παρόμοια τεκμήρια

Inhaled corticosteroids in COPD.
ανά: Brightling, C, κ.ά.
Έκδοση: (1999)

Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations
ανά: McKeever, T, κ.ά.
Έκδοση: (2018)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
ανά: Bafadhel, M, κ.ά.
Έκδοση: (2014)

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
ανά: Saha, S, κ.ά.
Έκδοση: (2006)

Inhaled corticosteroids in COPD (multiple letters) [1]
ανά: Hart, S, κ.ά.
Έκδοση: (1999)

Aspergillus fumigatus during stable state and exacerbations of COPD.
ανά: Bafadhel, M, κ.ά.
Έκδοση: (2014)

The Use of Inhaled Corticosteroids to Prevent Acute Exacerbations of COPD: A Pro/Con Debate
ανά: Russell, R, κ.ά.
Έκδοση: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
ανά: Siddiqui, S, κ.ά.
Έκδοση: (2018)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
ανά: Barker, B, κ.ά.
Έκδοση: (2015)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
ανά: Bafadhel, M, κ.ά.
Έκδοση: (2016)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
ανά: Siddiqui SH, κ.ά.
Έκδοση: (2018-11-01)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
ανά: Eltboli, O, κ.ά.
Έκδοση: (2014)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
ανά: Jose R. Jardim, κ.ά.
Έκδοση: (2019-04-01)

Exacerbations of COPD
ανά: Pavord ID, κ.ά.
Έκδοση: (2016-02-01)

Lung microbiome dynamics in COPD exacerbations
ανά: Wang, Z, κ.ά.
Έκδοση: (2016)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
ανά: Russell, R, κ.ά.
Έκδοση: (2019)

Is it time to give up on "self-management" of COPD exacerbations?
ανά: Ramakrishnan, S, κ.ά.
Έκδοση: (2020)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.
ανά: Siva, R, κ.ά.
Έκδοση: (2014)

COPD exacerbation phenotypes: The next frontier
ανά: Moran, A, κ.ά.
Έκδοση: (2019)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
ανά: Bafadhel M, κ.ά.
Έκδοση: (2015-06-01)

Biological exacerbation clusters demonstrate asthma and COPD overlap with distinct mediator and microbiome profiles
ανά: Ghebre, M, κ.ά.
Έκδοση: (2018)

Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
ανά: Bafadhel, M, κ.ά.
Έκδοση: (2011)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
ανά: Russell REK, κ.ά.
Έκδοση: (2019-05-01)

Benralizumab for the prevention of COPD exacerbations
ανά: Criner, G, κ.ά.
Έκδοση: (2019)

The role of CT scanning in multidimensional phenotyping of COPD.
ανά: Bafadhel, M, κ.ά.
Έκδοση: (2011)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
ανά: Helen F. Ashdown, κ.ά.
Έκδοση: (2021-02-01)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
ανά: Siva R, κ.ά.
Έκδοση: (2014-02-01)

Use of dry powder inhalers in acute exacerbations of asthma and COPD
ανά: Olof Selroos, κ.ά.
Έκδοση: (2009-04-01)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
ανά: Siva, R, κ.ά.
Έκδοση: (2007)

Prednisolone response in patients with COPD.
ανά: Pavord, I, κ.ά.
Έκδοση: (2004)

Eosinophils in COPD: just another biomarker?
ανά: Bafadhel, M, κ.ά.
Έκδοση: (2017)

Characterising non-eosinophilic COPD
ανά: Hambleton, K, κ.ά.
Έκδοση: (2015)

Cognitive function and inhaler technique following recovery from exacerbations of COPD
ανά: Benjamin E. Henkle, κ.ά.
Έκδοση: (2023-05-01)

COPD exacerbations: transforming outcomes through research
ανά: Hurst, JR, κ.ά.
Έκδοση: (2018)

Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST
ανά: McKeever, T, κ.ά.
Έκδοση: (2018)

Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study
ανά: Jing Zhang, κ.ά.
Έκδοση: (2018-04-01)

Blood eosinophil count and exacerbation risk in patients with COPD.
ανά: Kerkhof, M, κ.ά.
Έκδοση: (2017)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
ανά: Djamin, R, κ.ά.
Έκδοση: (2019)

Renaming COPD exacerbations: the UK respiratory nursing perspective
ανά: Christine Mwasuku, κ.ά.
Έκδοση: (2021-09-01)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
ανά: Vestbo J, κ.ά.
Έκδοση: (2019-04-01)